团体心理治疗对躯体形式障碍患者的影响

Effect of group psychotherapy on somatoform disorders

摘要:

目的探讨团队心理治疗对躯体形式障碍患者早期干预的疗效。方法选取2014 年10 月-2015 年1 月海南省儋州市农垦那大医院收治的躯体形式障碍患者97 例，依据随机数表法分为A 组（团体心理治疗32例）、B 组（药物治疗33 例）、C 组（团队心理治疗+ 药物治疗32 例），比较3 组患者的临床疗效和躯体形式症状筛查量表（SOMS-7）、大体评定量表（GAS）及汉密尔顿抑郁量表（HAMD)评分。结果A组显效率为62.50%，好转率为81.25%；B 组显效率为63.64%，好转率为84.85%；C 组显效率为87.50%，好转率为96.88%，组间比较，差异有统计学意义（p <0.05），C 组患者的显效率和好转率高于A、B 组。治疗前，3 组患者的SOMS-7 评分比较，差异无统计学意义（p >0.05）。治疗后48 周，A 组、B 组及C 组的SOMS-7 评分为（10.44±2.17）、（10.72±2.11）和（6.75±2.09）分，经方差分析，差异有统计学意义（p <0.05）。C 组的SOMS-7 评分低于A、B组。治疗前，3 组患者的GAS 评分比较，差异无统计学意义（p >0.05）。治疗后48 周，A 组、B 组及C 组的GAS 评分为（76.18±5.44）、（77.29±5.19）和（84.25±5.91）分，经检验，差异有统计学意义（p <0.05）。C 组的GAS 评分高于A、B组。3 组患者的HAMD评分比较，差异无统计学意义（p >0.05）。治疗后48 周3 组患者的HAMD 评分比较，差异有统计学意义（p <0.05），C组患者的HAMD评分低于A、B组。结论团体心理治疗联合药物使用在治疗躯体形式障碍方面成效好，能够改善患者精神状况及临床症状。

Abstract:

Objective To evaluate the efficacy of team psychotherapy for early intervention of somatoform disorders. Methods According to a random number, 97 patients with somatoform disorders treated in Danzhou Agricultural Reclamation Nada Hospital from October 2014 to January 2015 were assigned into group A (32 cases who received team psychotherapy), group B (33 cases who received medication) and group C (32 cases who received both team psychotherapy and medication). The clinical efficacy, Somatoform Symptoms Screening Scale (Chinese version SOMS-7) score, Global Assessment Scale (GAS) score and Hamilton Depression Scale (HAMD) score were campared among the three groups. Results In the group A, the effective rate was 62.50%, the improvement rate was 81.25%; in the group B, the effective rate was 63.64%, the improvement rate was 84.85%; in the group C, the effective rate was 87.50%, the improvement rate was 96.88%, the effective rate and the improvement rate of the group C were higher than those of the groups A and B (p <0.05). Before treatment, there were no significant differences in the SOMS-7 score among the three groups (p >0.05). In the 48th week after treatment, the SOMS-7 score of the groups A, B and C was (10.44 ±2.17),(10.72 ±2.11) and (6.75 ±2.09) respectively; the SOMS-7 score of the group C was lower than that of the group A and the group B (p < 0.05). Before treatment, there were no significant differences in the GAS score among the three groups (p > 0.05). In the 48th week after treatment, the GAS score of the groups A, B and C was (76.18 ±5.44), (77.29 ±5.19) and (84.25 ±5.91) respectively; the GAS score of the group C was higher than that of the group A and the group B (p < 0.05). There were no significant differences in the HAMD score among the three groups before treatment (p > 0.05). The HAMD score in the group C was lower than that in the group A and the group B (p < 0.05), and the differences were statistically significant (p < 0.05). Conclusions Combined use of group psychotherapy and drug has achieved remarkable success in the treatment of somatoform disorders, and can significantly improve patients' mental health and clinical symptoms.